Clinical & Pharma

Virginia Must Break the Silence on Men’s Mental Health
Clinical & Pharma Virginia Must Break the Silence on Men’s Mental Health

The picturesque landscapes of the Blue Ridge Mountains and the bustling shipyards of Hampton Roads often mask a pervasive and silent crisis that is currently undermining the psychological foundation of men throughout the Commonwealth of Virginia. While public awareness campaigns and the observation

Digital Delivery Modernizes Patient Information Leaflets
Clinical & Pharma Digital Delivery Modernizes Patient Information Leaflets

The traditional folded paper insert tucked inside medication packaging has remained virtually unchanged for decades, yet it now faces an unprecedented level of scrutiny as healthcare moves toward a more agile and digitally connected future. For over a quarter of a century, the Patient Information

How Can Student Champions Transform Suicide Prevention?
Clinical & Pharma How Can Student Champions Transform Suicide Prevention?

The landscape of adolescent mental health is undergoing a profound transformation as schools increasingly look toward their own students to bridge the gap between clinical resources and the hallways where crisis often begins. Traditional models of suicide prevention have long relied on a top-down

Can Natco Pharma’s $260M Move Transform African Healthcare?
Clinical & Pharma Can Natco Pharma’s $260M Move Transform African Healthcare?

The pharmaceutical landscape across the African continent has long been defined by a precarious reliance on external suppliers, but Natco Pharma is currently challenging this status quo with a decisive two hundred and sixty million dollar investment into the South African medical infrastructure.

Why Is the NIH Essential for Medical Innovation?
Clinical & Pharma Why Is the NIH Essential for Medical Innovation?

The intricate network of modern medical advancement relies on a foundational structure that many observers frequently overlook until a global health crisis forces it into the spotlight. As the primary engine for American biomedical science, the National Institutes of Health functions as the

Insilico and Bora Form $2.5 Billion AI Drug Alliance
Clinical & Pharma Insilico and Bora Form $2.5 Billion AI Drug Alliance

The pharmaceutical industry has long grappled with a massive disconnect between the rapid pace of computational drug discovery and the often-stagnant timelines of physical manufacturing and distribution. In a move designed to bridge this gap, Insilico Medicine and Bora Pharmaceuticals have entered

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later